Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President & CEO

EVP & Chief Business Officer

Co-Chief Executive Officer

See Remarks

Chief Medical Officer

President & Co-CEO

Chief Executive Officer

COO and Chief Medical Officer

EVP, CFO and Treasurer

EVP and COO

EVP, Head Global Clin Research

Chief Commercial Officer

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for other neurodegenerative diseases. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therap...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-07	Premium	acquired	Premium	Premium	Premium	President & CEO
2024-05-06	Premium	acquired	Premium	Premium	Premium	President & CEO
2024-04-19	Premium	acquired	Premium	Premium	Premium	President & CEO
2024-04-18	Premium	acquired	Premium	Premium	Premium	President & CEO
2024-04-17	Premium	acquired	Premium	Premium	Premium	President & CEO
2024-03-11	Premium	acquired	Premium	Premium	Premium	EVP & Chief Business Officer
2024-03-11	Premium	acquired	Premium	Premium	Premium	President & CEO
2024-03-11	Premium	acquired	Premium	Premium	Premium	Co-Chief Executive Officer
2024-03-11	Premium	acquired	Premium	Premium	Premium	See Remarks
2023-09-01	Premium	bought	Premium	Premium	Premium	Co-Chief Executive Officer
2023-08-02	Premium	acquired	Premium	Premium	Premium	Co-Chief Executive Officer
2023-08-02	Premium	acquired	Premium	Premium	Premium	President & CEO
2023-06-19	Premium	acquired	Premium	Premium	Premium	-
2023-05-01	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-04-20	Premium	acquired	Premium	Premium	Premium	Co-Chief Executive Officer
2023-04-20	Premium	acquired	Premium	Premium	Premium	President & Co-CEO
2022-12-07	Premium	acquired	Premium	Premium	Premium	Co-Chief Executive Officer
2022-09-18	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-03-06	Premium	acquired	Premium	Premium	Premium	COO and Chief Medical Officer
2022-02-01	Premium	acquired	Premium	Premium	Premium	-
2021-12-15	Premium	acquired	Premium	Premium	Premium	-
2021-12-15	Premium	acquired	Premium	Premium	Premium	-
2021-12-15	Premium	acquired	Premium	Premium	Premium	-
2021-12-10	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2021-12-10	Premium	acquired	Premium	Premium	Premium	-

BCLI - BrainStorm Cell Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for BCLI